Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 5
2020 12
2021 18
2022 13
2023 9
2024 21
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Teunissen CE, et al. Among authors: verberk imw. Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24. Lancet Neurol. 2022. PMID: 34838239 Review.
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.
Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, Zetterberg H, Bateman RJ, Scheltens P, Blennow K, Sperling R, Hansson O, Jack CR Jr, Rosa-Neto P. Therriault J, et al. Among authors: verberk i. Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1. Nat Rev Neurol. 2024. PMID: 38429551 Review.
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.
Janelidze S, Teunissen CE, Zetterberg H, Allué JA, Sarasa L, Eichenlaub U, Bittner T, Ovod V, Verberk IMW, Toba K, Nakamura A, Bateman RJ, Blennow K, Hansson O. Janelidze S, et al. Among authors: verberk imw. JAMA Neurol. 2021 Nov 1;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180. JAMA Neurol. 2021. PMID: 34542571 Free PMC article.
Adaptive immune changes associate with clinical progression of Alzheimer's disease.
van Olst L, Kamermans A, Halters S, van der Pol SMA, Rodriguez E, Verberk IMW, Verberk SGS, Wessels DWR, Rodriguez-Mogeda C, Verhoeff J, Wouters D, Van den Bossche J, Garcia-Vallejo JJ, Lemstra AW, Witte ME, van der Flier WM, Teunissen CE, de Vries HE. van Olst L, et al. Among authors: verberk imw. Mol Neurodegener. 2024 Apr 24;19(1):38. doi: 10.1186/s13024-024-00726-8. Mol Neurodegener. 2024. PMID: 38658964 Free PMC article.
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals.
Del Campo M, Quesada C, Vermunt L, Peeters CFW, Hok-A-Hin YS, Trieu C, Braber AD, Verberk IMW, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. Del Campo M, et al. Among authors: verberk imw. Mol Neurodegener. 2024 Nov 11;19(1):82. doi: 10.1186/s13024-024-00767-z. Mol Neurodegener. 2024. PMID: 39523360 Free PMC article.
Performance of plasma p-tau217 and NfL in an unselected memory clinic setting.
Rousset RZ, Claessen T, van Harten AC, Lemstra AW, Pijnenburg YAL, van der Flier WM, den Braber A, Jeromin A, Verberk IMW, Teunissen CE. Rousset RZ, et al. Among authors: verberk imw. Alzheimers Dement (Amst). 2024 Nov 23;16(4):e70003. doi: 10.1002/dad2.70003. eCollection 2024 Oct-Dec. Alzheimers Dement (Amst). 2024. PMID: 39583647 Free PMC article.
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217.
Wojdała AL, Vanbrabant J, Bayoumy S, Antwi-Berko D, Bastard NL, van der Flier WM, Jeromin A, Lambrechts C, Van Loo M, Vandijck M, Stoops E, Verberk IMW, Teunissen CE. Wojdała AL, et al. Among authors: verberk imw. Alzheimers Res Ther. 2024 Dec 19;16(1):266. doi: 10.1186/s13195-024-01630-5. Alzheimers Res Ther. 2024. PMID: 39702308 Free PMC article.
Identifying pathways to the prevention of dementia: the Netherlands consortium of dementia cohorts.
Oomens JE, Moonen JEF, Vos SJB, Beran M, Mateus P, De Deyn PP, van der Flier WM, Geerlings MI, Huisman MA, Ikram MA, Schram MT, Slagboom PE, Verschuren WMM, Beekman M, Bermejo I, Birhanu M, Bron EE, Dekker A, Frentz I, Garst SJF, Jaarsma E, Kok AAL, Marcolini S, Mei L, van Charante EPM, Richard E, Schalkwijk CG, van Sloten TT, Teunissen CE, Twait EL, Verberk IMW, Vonk JMJ, van de Waarenburg MPH, Wolters FJ, Jansen WJ, Visser PJ. Oomens JE, et al. Among authors: verberk imw. BMC Neurol. 2025 Feb 12;25(1):59. doi: 10.1186/s12883-024-03995-4. BMC Neurol. 2025. PMID: 39939930 Free PMC article.
Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
Trieu C, van Harten AC, Leeuwis AE, Exalto LG, Hooghiemstra AM, Verberk IMW, Allaart CP, Brunner-La Rocca HP, Kappelle LJ, van Oostenbrugge RJ, Biessels GJ, Teunissen CE, van der Flier WM; Heart-Brain Connection Consortium. Trieu C, et al. Among authors: verberk imw. J Alzheimers Dis. 2024;98(3):987-1000. doi: 10.3233/JAD-231096. J Alzheimers Dis. 2024. PMID: 38489178 Free PMC article.
80 results